Safety and efficacy of orlistat (Xenical; Roche) in African American and Caucasian children and adolescents with obesity-related comorbid conditions.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 18 Jun 2013 Primary endpoint 'Body-mass-index' has been met according to results presented at the 95th Annual Meeting of the Endocrine Society.
- 18 Jun 2013 Results presented at the 95th Annual Meeting of the Endocrine Society.
- 26 Oct 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.